UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism

European neuropsychopharmacology, 2022-09, Vol.62, p.22-35

2022

Volltextzugriff (PDF)

Enhancement of the antipsychotic effect of risperidone by sodium nitroprusside in rats

European neuropsychopharmacology, 2019-11, Vol.29 (11), p.1282-1287

2019

Volltextzugriff (PDF)

The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism

European neuropsychopharmacology, 2017-04, Vol.27 (4), p.411-417

2017

Volltextzugriff (PDF)

Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat

Progress in neuro-psychopharmacology & biological psychiatry, 2012-10, Vol.39 (1), p.143-148

2012

Volltextzugriff (PDF)

Sodium nitroprusside but not molsidomine may be used for antipsychotic augmentation in treatment resistant schizophrenia

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, Vol.29, p.S424-S425

2019

Volltextzugriff (PDF)

Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia

European neuropsychopharmacology, 2018-05, Vol.28 (5), p.620-629

2018

Volltextzugriff (PDF)

Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study

European neuropsychopharmacology, 2016-09, Vol.26 (9), p.1401-1411

2016

Volltextzugriff (PDF)

Rapid augmentation of antipsychotic drugs by sodium nitroprusside: behavioural assessment and effect on brain dopaminergic transmission in rats

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, Vol.27, p.S47-S47

2017

Volltextzugriff (PDF)

Lumateperone increases glutamate release in the rat medial prefrontal cortex

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2021, Vol.53, p.S556

2021

Volltextzugriff (PDF)

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine

European neuropsychopharmacology, 2013-07, Vol.23 (7), p.709-720

2013

Volltextzugriff (PDF)

Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat

The international journal of neuropsychopharmacology, 2015, Vol.18 (3), p.pyu068-pyu068

2015

Volltextzugriff (PDF)

Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat

Synapse (New York, N.Y.), 2011-05, Vol.65 (5), p.357-367

2011

Volltextzugriff (PDF)

The novel atypical antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, Vol.26, p.S235-S236

2016

Volltextzugriff (PDF)

Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: Involvement of dopamine D1 receptors

Synapse (New York, N.Y.), 2010-11, Vol.64 (11), p.870-874

2010

Volltextzugriff (PDF)

Rational antibody design for undruggable targets using kinetically controlled biomolecular probes

Science advances, 2021-04, Vol.7 (16)

2021

Volltextzugriff (PDF)

Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission

Psychopharmacologia, 2012-05, Vol.221 (1), p.115-131

2012

Volltextzugriff (PDF)

Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: Behavioral, biochemical, and electrophysiological evidence

Synapse (New York, N.Y.), 2012-04, Vol.66 (4), p.277-290

2012

Volltextzugriff (PDF)

Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms

Psychopharmacologia, 2009-06, Vol.204 (2), p.251-264

2009

Volltextzugriff (PDF)

Nicotine hapten structure, antibody selectivity and effect relationships: Results from a nicotine vaccine screening procedure

Vaccine, 2010-03, Vol.28 (10), p.2161-2168

2010

Volltextzugriff (PDF)

Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia

Psychopharmacologia, 2008-02, Vol.196 (3), p.417-429

2008

Volltextzugriff (PDF)

Reboxetine Enhances the Olanzapine-Induced Antipsychotic-Like Effect, Cortical Dopamine Outflow and NMDA Receptor-Mediated Transmission

Neuropsychopharmacology, 2010-08, Vol.35 (9), p.1952-1961

2010

Volltextzugriff (PDF)

Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow

Synapse (New York, N.Y.), 2012-07, Vol.66 (7), p.650-660

2012

Volltextzugriff (PDF)

Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex

Synapse (New York, N.Y.), 2006-08, Vol.60 (2), p.102-108

2006

Volltextzugriff (PDF)

Involvement of 5-HT2A receptor and a2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, Vol.15, p.49

2012

Volltextzugriff (PDF)

Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine

Synapse (New York, N.Y.), 2009-10, Vol.63 (10), p.913-920

2009

Volltextzugriff (PDF)

1 – 25 von 1.175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.132)
Mit Volltextzugriff
(1.027)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.104)
Technology
(563)
Computer Science
(552)
Life Sciences & Biomedicine
(491)
Computer Science, Software Engineering
(441)
Computer Science, Interdisciplinary Applications
(398)
Engineering
(366)
Ergonomics
(357)
Computer Science, Cybernetics
(339)
Humans
(321)
Computer Science, Theory & Methods
(319)
Male
(195)
Biological And Medical Sciences
(172)
Computer Science, Artificial Intelligence
(167)
Female
(151)
Animals
(143)
Medical Sciences
(137)
Adult
(116)
Medicin Och Hälsovetenskap
(111)
Pharmacology & Pharmacy
(109)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Lumateperone-mediated effects on prefrontal glutamatergic receptor-mediated neurotransmission: A dopamine D1 receptor dependent mechanism

Enhancement of the antipsychotic effect of risperidone by sodium nitroprusside in rats

The novel antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism

Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat

Sodium nitroprusside but not molsidomine may be used for antipsychotic augmentation in treatment resistant schizophrenia

Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia

Alpha7 nicotinic acetylcholine receptor agonists and PAMs as adjunctive treatment in schizophrenia. An experimental study

Rapid augmentation of antipsychotic drugs by sodium nitroprusside: behavioural assessment and effect on brain dopaminergic transmission in rats

Lumateperone increases glutamate release in the rat medial prefrontal cortex

Role of concomitant inhibition of the norepinephrine transporter for the antipsychotic effect of quetiapine

Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat

Effects of S-citalopram, citalopram, and R-citalopram on the firing patterns of dopamine neurons in the ventral tegmental area, N-methyl-D-aspartate receptor-mediated transmission in the medial prefrontal cortex and cognitive function in the rat

The novel atypical antipsychotic drug brexpiprazole, alone and in combination with escitalopram, facilitates prefrontal glutamatergic transmission via a dopamine D1 receptor-dependent mechanism

Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: Involvement of dopamine D1 receptors

Rational antibody design for undruggable targets using kinetically controlled biomolecular probes

Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission

Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: Behavioral, biochemical, and electrophysiological evidence

Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms

Nicotine hapten structure, antibody selectivity and effect relationships: Results from a nicotine vaccine screening procedure

Asenapine, a novel psychopharmacologic agent: preclinical evidence for clinical effects in schizophrenia

Reboxetine Enhances the Olanzapine-Induced Antipsychotic-Like Effect, Cortical Dopamine Outflow and NMDA Receptor-Mediated Transmission

Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow

Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex

Involvement of 5-HT2A receptor and a2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow

Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine

Suchergebnisse filtern